Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 1;314(5):F736-F746.
doi: 10.1152/ajprenal.00414.2016. Epub 2017 Sep 27.

Targeted γ-secretase inhibition of Notch signaling activation in acute renal injury

Jean-Christophe Wyss  1 , Rajesh Kumar  1 , Josip Mikulic  1 , Manfred Schneider  2 , Johannes D Aebi  2 , Lucienne Juillerat-Jeanneret  1   3 , Dela Golshayan  1
Affiliations
Free article

Targeted γ-secretase inhibition of Notch signaling activation in acute renal injury

Jean-Christophe Wyss et al. Am J Physiol Renal Physiol. .
Free article

Abstract

The Notch pathway has been reported to control tissue damage in acute kidney diseases. To investigate potential beneficial nephroprotective effects of targeting Notch, we developed chemically functionalized γ-secretase inhibitors (GSIs) targeting γ-glutamyltranspeptidase (γ-GT) and/or γ-glutamylcyclotransferase (γ-GCT), two enzymes overexpressed in the injured kidney, and evaluated them in in vivo murine models of acute tubular and glomerular damage. Exposure of the animals to disease-inducing drugs together with the functionalized GSIs improved proteinuria and, to some extent, kidney dysfunction. The expression of genes involved in the Notch pathway, acute inflammatory stress responses, and the renin-angiotensin system was enhanced in injured kidneys, which could be downregulated upon administration of functionalized GSIs. Immunohistochemistry staining and Western blots demonstrated enhanced activation of Notch1 as detected by its cleaved active intracellular domain during acute kidney injury, and this was downregulated by concomitant treatment with the functionalized GSIs. Thus targeted γ-secretase-based prodrugs developed as substrates for γ-GT/γ-GCT have the potential to selectively control Notch activation in kidney diseases with subsequent regulation of the inflammatory stress response and the renin-angiotensin pathways.

Keywords: Notch; aminopeptidase A; drug-targeting; kidney diseases; renin-angiotensin; γ-GT; γ-glutamyltranspeptidase; γ-secretase inhibitors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources